xRead - September 2022

Wise et al.

Page 185

53. Snyder RD, Snyder LB. Intranasal cocaine abuse in an allergists office. Ann Allergy. 1985;54:489– 492. [PubMed: 4014778] 54. Hall LJ, Jackson RT. Effects of alpha and beta adrenergic agonists on nasal blood flow. Ann Otol Rhinol Laryngol. 1968;77:1120–1130. [PubMed: 5724413] 55. Walker JS. Rhinitis medicamentosa. J Allergy. 1952;23:183–186. [PubMed: 14907289] 56. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. CJEM. 2010;12:158–161. [PubMed: 20219165] 57. Sataloff RT, Gullane PJ, Goldstein DP. Sataloff’s Comprehensive Textbook of Otolaryngology, Head and Neck Surgery. New Delhi: Jaypee Brothers Medical Publishing; 2016. 58. Daws LC, Callaghan PD, Moron JA, et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun. 2002;290:1545–1550. [PubMed: 11820798] 59. Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Addiction. 2011;106:1460–1473. [PubMed: 21395892] 60. Zhang H, Prisinzano TE, Donovan MD. Permeation and metabolism of cocaine in the nasal mucosa. Eur J Drug Metab Pharmacokinet. 2012;37:255–262. [PubMed: 22351075] 61. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16:148–155. 62. Graf PM. Rhinitis medicamentosa. Clin Allergy Immunol. 2007;19:295–304. [PubMed: 17153021] 63. Min YG, Kim HS, Suh SH, Jeon SY, Son YI, Yoon S. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta Otolaryngol. 1996;116:465–471. [PubMed: 8790749] 64. Graf P, Juto JE. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology. 1995;33:14–17. [PubMed: 7540314] 65. Bralow L Vicks Sinex PDR. Montvale, NJ: Thomson, 2004. 66. Fleece L, Mizes JS, Jolly PA, Baldwin RL. Rhinitis medicamentosa. Conceptualization, incidence, and treatment. Ala J Med Sci. 1984;21:205–208. [PubMed: 6375416] 67. Knipping S, Holzhausen HJ, Goetze G, Riederer A, Bloching MB. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa. Otolaryngol Head Neck Surg. 2007;136:57–61. [PubMed: 17210334] 68. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130:131–141. [PubMed: 14726922] 69. Graf P Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa. Clin Ther. 1999;21:1749–1755. [PubMed: 10566570] 70. Graf P Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med. 2005;4:21– 29. [PubMed: 15725047] 71. Graf P Benzalkonium chloride as a preservative in nasal solutions: re-examining the data. Respir Med. 2001;95:728–733. [PubMed: 11575893] 72. Morris S, Eccles R, Martez SJ, Riker DK, Witek TJ. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion. Am J Rhinol. 1997;11:109–115. [PubMed: 9129752] 73. Chodirker WB. Rhinitis medicamentosa. Can Med Assoc J. 1981;124:370, 372. 74. May M, West JW. The “stuffy” nose. Otolaryngol Clin North Am. 1973;6:655–674. [PubMed: 4220316] 75. Graf P, Hallen H, Juto JE. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol Allied Sci. 1995;20:224–229. [PubMed: 7554332] 76. Elwany S, Abdel-Salaam S. Treatment of rhinitis medicamentosa with fluticasone propionate—an experimental study. Eur Arch Otorhinolaryngol. 2001;258:116–119. [PubMed: 11374251] 77. Tas A, Yagiz R, Yalcin O, et al. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study. Otolaryngol Head Neck Surg. 2005;132:608–612. [PubMed: 15806055]

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.